Skip to main content
David Haslam, MD, Pediatric Infectious Disease, Cincinnati, OH

DavidBruceHaslamMD

Pediatric Infectious Disease Cincinnati, OH

Associate Professor, Pediatrics, Cincinnati Children's Hospital

Dr. Haslam is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Haslam's full profile

Already have an account?

  • Office

    3333 Burnet Ave
    Cincinnati, OH 45229
    Phone+1 513-636-4578
    Fax+1 513-636-7039

Education & Training

  • University of Calgary Faculty of Medicine
    University of Calgary Faculty of MedicineClass of 1987
  • University of Calgary
    University of CalgaryBS, Cellular, Microbial, and Molecular Biology, 1984
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Pediatric Infectious Diseases

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2013 - 2026
  • MO State Medical License
    MO State Medical License 1996 - 2016
  • American Board of Pediatrics Pediatric Infectious Diseases

Publications & Presentations

PubMed

Journal Articles

  • Antibiotic Exposure and Reduced Short Chain Fatty Acid Production After Hematopoietic Stem Cell Transplant  
    David B Haslam, Lee Denson, Christopher E Dandoy, Stella M Davies, Biology of Blood and Marrow Transplantation
  • Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling  
    Giles DA, Moreno-Fernandez ME, Stankiewicz TE, Graspeuntner S, Cappelletti M, Wu D, Mukherjee R, Chan CC, Lawson MJ, Klarquist J, et al, Nature Medicine, 1/1/2017
  • Performance of the check-points check-MDR CT103XL assay utilizing the CDC/FDA antimicrobial resistance isolate bank  
    Powell EA, Haslam D, Mortensen JE, Diagn Microbiol Infect Dis, 1/1/2017
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Press Mentions

  • Are the Additives in Our Food Making Us Ill?
    Are the Additives in Our Food Making Us Ill?September 22nd, 2020
  • Trust Me I’m Not a Doctor
    Trust Me I’m Not a DoctorSeptember 16th, 2020
  • Heroes in the Race to Save Antibiotics
    Heroes in the Race to Save AntibioticsJune 9th, 2017
  • Join now to see all

Grant Support

  • An HTS Assay For Inhibitors Of C. Difficle ToxinsNational Institute Of Neurological Disorders And Stroke2009
  • Role Of MK2 Kinase In Toxin-Associated DiseaseNational Institute Of Allergy And Infectious Diseases2009
  • A Screen For Small Molecule Inhibitors Of Shiga Toxin And Ricin ActivityNational Institute Of Mental Health2008–2009
  • Discovery Of Novel Therapeutics Against Shiga And Ricin ToxinsNational Institute Of Allergy And Infectious Diseases2008
  • A Screen For Small Molecule Compounds That Inhibit Bacterial ToxinsNational Institute Of Mental Health2007–2008
  • Role Of Er-Localized Chaperones In Toxin PathogenesisNational Institute Of Allergy And Infectious Diseases2003–2006
  • Er-Localized Chaperones In Toxin PathogenesisNational Institute Of Allergy And Infectious Diseases2002
  • Glycolipids And Hemolytic Uremic SyndromeNational Institute Of Allergy And Infectious Diseases1998–2002
  • Regulation Of Globopentosylceramide ExpressionEunice Kennedy Shriver National Institute Of Child Health &Human Development1995–1996